ES2700901B2 - Proceso para la preparación de 3ß-hidroxi-17-(1h-benzimidazol-1-il)androsta-5,16-dieno. - Google Patents
Proceso para la preparación de 3ß-hidroxi-17-(1h-benzimidazol-1-il)androsta-5,16-dieno. Download PDFInfo
- Publication number
- ES2700901B2 ES2700901B2 ES201990014A ES201990014A ES2700901B2 ES 2700901 B2 ES2700901 B2 ES 2700901B2 ES 201990014 A ES201990014 A ES 201990014A ES 201990014 A ES201990014 A ES 201990014A ES 2700901 B2 ES2700901 B2 ES 2700901B2
- Authority
- ES
- Spain
- Prior art keywords
- androsta
- benzimidazol
- diene
- hydroxy
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PAFKTGFSEFKSQG-PAASFTFBSA-N Galeterone Chemical compound C1=NC2=CC=CC=C2N1C1=CC[C@H]2[C@H](CC=C3[C@@]4(CC[C@H](O)C3)C)[C@@H]4CC[C@@]21C PAFKTGFSEFKSQG-PAASFTFBSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102016000083406A IT201600083406A1 (it) | 2016-08-08 | 2016-08-08 | PROCESSO PER LA PREPARAZIONE DI 3β-IDROSSI-17-(1H-BENZIMIDAZOL-1-IL)ANDROSTA-5,16-DIENE |
| IT102016000121375A IT201600121375A1 (it) | 2016-11-30 | 2016-11-30 | PROCESSO PER LA PREPARAZIONE DI 3ß-IDROSSI-17-(1H-BENZIMIDAZOL-1-IL)ANDROSTA-5,16-DIENE |
| PCT/EP2017/070124 WO2018029223A1 (en) | 2016-08-08 | 2017-08-08 | PROCESS FOR THE PREPARATION OF 3ß-HYDROXY-17-(1H-BENZIMIDAZOL-1-YL)ANDROSTA-5,16-DIENE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ES2700901A2 ES2700901A2 (es) | 2019-02-19 |
| ES2700901R1 ES2700901R1 (es) | 2019-03-04 |
| ES2700901B2 true ES2700901B2 (es) | 2019-08-06 |
Family
ID=59745873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201990014A Active ES2700901B2 (es) | 2016-08-08 | 2017-08-08 | Proceso para la preparación de 3ß-hidroxi-17-(1h-benzimidazol-1-il)androsta-5,16-dieno. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11390645B2 (es) |
| CA (1) | CA3063339C (es) |
| CH (1) | CH714173B1 (es) |
| ES (1) | ES2700901B2 (es) |
| RU (1) | RU2749134C1 (es) |
| WO (1) | WO2018029223A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024091899A1 (en) * | 2022-10-25 | 2024-05-02 | University Of Maryland, Baltimore | Salts of galeterone and salts of next generation galeterone analogs, and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101380959B1 (ko) * | 2005-03-02 | 2014-04-04 | 유니버시티 오브 매릴랜드, 발티모어 | 신규 c-17-헤테로아릴 스테로이드성 cyp17억제제/항안드로겐:합성, 시험관내 생물학적 활성,약물동태학 및 항종양 활성 |
| WO2016119742A1 (zh) * | 2015-01-29 | 2016-08-04 | 苏州晶云药物科技有限公司 | (3β)-17-(1H-苯并咪唑-1-基)雄甾-5,16-二烯-3-醇的盐及其制备方法 |
| CN112851741B (zh) * | 2016-02-19 | 2022-10-25 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的甾体类化合物及其应用 |
-
2017
- 2017-08-08 ES ES201990014A patent/ES2700901B2/es active Active
- 2017-08-08 RU RU2019143855A patent/RU2749134C1/ru active
- 2017-08-08 US US16/323,317 patent/US11390645B2/en active Active
- 2017-08-08 CH CH00147/19A patent/CH714173B1/it unknown
- 2017-08-08 CA CA3063339A patent/CA3063339C/en active Active
- 2017-08-08 WO PCT/EP2017/070124 patent/WO2018029223A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA3063339A1 (en) | 2018-02-15 |
| WO2018029223A1 (en) | 2018-02-15 |
| ES2700901A2 (es) | 2019-02-19 |
| ES2700901R1 (es) | 2019-03-04 |
| US11390645B2 (en) | 2022-07-19 |
| US20210284681A1 (en) | 2021-09-16 |
| RU2749134C1 (ru) | 2021-06-04 |
| CH714173B1 (it) | 2021-04-15 |
| CA3063339C (en) | 2024-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3278613A4 (en) | Ofdma sounding for wlan system | |
| EP3248208A4 (en) | Fourier ptychographic tomography | |
| EP3263544A4 (en) | Method for producing 1-chloro-2,3,3-trifluoropropene | |
| EP3287439A4 (en) | Method for preparing taurine | |
| LT3390390T (lt) | Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui | |
| ES2837136R1 (es) | Proceso para la preparación de 3alfa-hidroxi-5alfa-pregnan-20-ona (Brexanolona) | |
| EP3280408A4 (en) | Process for the preparation of dicycloplatin | |
| GB2540427B (en) | Process for the preparation of 2,3,3,3-tetrafluoropropene (1234yf) | |
| IL260465B (en) | A process for preparing an antibody-rifamycin conjugate | |
| EP3178803A4 (en) | Method for preparing 2,3,3,3-tetrafluoropropene | |
| GB2540428B (en) | Process for preparing 3,3,3-trifluoropropene | |
| EP3390368A4 (en) | PROCESS FOR PREPARING SUBSTITUTED 5,6-DIHYDRO-6-PHENYL BENZO [F] ISOCHINOLINE-2-AMINE | |
| PL3199516T3 (pl) | Sposób wytwarzania Metaraminolu | |
| EP3330244A4 (en) | Production method for 2,3,3,3-tetrafluoropropene | |
| GB2561089B (en) | Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one | |
| EP3296287A4 (en) | Method for purifying 1,4-diaminobutane | |
| PT3350150T (pt) | 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização | |
| HUE043347T2 (hu) | Eljárás folyamatos zsírfázisú, zsírban szegény emulziók elõállítására | |
| EP3253772B8 (en) | Process for the preparation of diosmin | |
| SG11201704201VA (en) | Catalyst and preparation method thereof, and method for preparing isobutylene by applying the same | |
| EP3202755A4 (en) | Method for producing 2, 3, 3,3-tetrafluoropropene | |
| ES2700901B2 (es) | Proceso para la preparación de 3ß-hidroxi-17-(1h-benzimidazol-1-il)androsta-5,16-dieno. | |
| ES3059582T3 (en) | Sulfamate derivative compounds, processes for preparing them and their uses | |
| EP3395442A4 (en) | Catalyst preparation method | |
| IL251229B (en) | Process for preparing 5-bromo-1,2,3-trichlorobenzene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA2A | Patent application published |
Ref document number: 2700901 Country of ref document: ES Kind code of ref document: A2 Effective date: 20190219 |
|
| EC2A | Search report published |
Ref document number: 2700901 Country of ref document: ES Kind code of ref document: R1 Effective date: 20190225 |
|
| FG2A | Definitive protection |
Ref document number: 2700901 Country of ref document: ES Kind code of ref document: B2 Effective date: 20190806 |